|
1
|
World Health Organization: COVID-19
Epidemiological update-27 October 2023. Available from: https://www.who.int/publications/m/item/covid-19-epidemiological-update-27-october-2023.
|
|
2
|
Minsa. Cocid-19 Situation Room. COVID-19
situation. 2022. Available from: https://www.dge.gob.pe/covid19.html.
|
|
3
|
Huang I, Lim MA and Pranata R: Diabetes
mellitus is associated with increased mortality and severity of
disease in COVID-19 pneumonia-A systematic review, meta-analysis,
and meta-regression. Diabetes Metab Syndr. 14:395–403.
2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Kumar A, Arora A, Sharma P, Anikhindi SA,
Bansal N, Singla V, Khare S and Srivastava A: Is diabetes mellitus
associated with mortality and severity of COVID-19? A
meta-analysis. Diabetes Metab Syndr. 14:535–545. 2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Guo L, Shi Z, Zhang Y, Wang C, Do Vale
Moreira NC, Zuo H and Hussain A: Comorbid diabetes and the risk of
disease severity or death among 8807 COVID-19 patients in China: A
meta-analysis. Diabetes Res Clin Pract. 166(108346)2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Wargny M, Potier L, Gourdy P, Pichelin M,
Amadou C, Benhamou PY, Bonnet JB, Bordier L, Bourron O, Chaumeil C,
et al: Predictors of hospital discharge and mortality in patients
with diabetes and COVID-19: Updated results from the nationwide
CORONADO study. Diabetologia. 64:778–794. 2021.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Corona G, Pizzocaro A, Vena W, Rastrelli
G, Semeraro F, Isidori AM, Pivonello R, Salonia A, Sforza A and
Maggi M: Diabetes is most important cause for mortality in COVID-19
hospitalized patients: Systematic review and meta-analysis. Rev
Endocr Metab Disord. 22:275–296. 2021.PubMed/NCBI View Article : Google Scholar
|
|
8
|
GBD 2021 Diabetes Collaborators. Global,
regional, and national burden of diabetes from 1990 to. 2021, with
projections of prevalence to 2050: A systematic analysis for the
global burden of disease study 2021. Lancet. 402:203–234.
2023.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Lei F, George K and Michael R: Coronavirus
spike protein and receptor, illustration. Lancet Respir Med.
8(e21)2019.
|
|
10
|
World Health Organization: Laboratory
testing for coronavirus disease 2019 (COVID-19) in suspected human
cases: Interim guidance, 2 March 2020.
|
|
11
|
ElSayed NA, Aleppo G, Bannuru RR, Bruemmer
D, Collins BS, Ekhlaspour L, Gaglia JL, Hilliard ME, Johnson EL,
Khunt K, et al: Diagnosis and classification of diabetes: Standards
of care in diabetes-2024. Diabetes Care. 47 (Suppl 1):S20–S42.
2024.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Rhee MK, Ho YL, Raghavan S, Vassy JL, Cho
K, Gagnon D, Staimez LR, Ford CN, Wilson PWF and Phillips LS:
Random plasma glucose predicts the diagnosis of diabetes. PLoS One.
14(e0219964)2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Association American Diabetes. 2.
Classification and diagnosis of diabetes: Standards of medical care
in diabetes-2021. Diabetes Care. 44 (Suppl 1):S15–S33.
2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Wickham H, Averick M, Bryan J, Chang W,
McGowan L, François R, Grolemund G, Hayes A, Henry L, Hester J, et
al: Welcome to the Tidyverse. J Open Source Softw. 4(1686)2019.
|
|
15
|
Sjoberg DD, Whiting K, Curry M, Lavery JA
and Larmarange J: Reproducible summary tables with the gtsummary
package. R J. 13:570–580. 2021.
|
|
16
|
Lüdecke D, Ben-Shachar M, Patil I,
Waggoner P and Makowski D: Performance: An R package for
assessment, comparison and testing of statistical models. J Open
Source Softw. 6(3139)2021.
|
|
17
|
Kassambara A and Mundt F: factoextra:
Extract and visualize the results of multivariate data analyses.
Package Version 1.0.7. R Packag version, 2020. Available from:
https://cran.r-project.org/web/packages/factoextra/readme/README.html.
|
|
18
|
Dessie ZG and Zewotir T: Mortality-related
risk factors of COVID-19: A systematic review and meta-analysis of
42 studies and 423,117 patients. BMC Infect Dis.
21(855)2021.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Soto A, Quiñones-Laveriano DM, Azañero J,
Chumpitaz R, Claros J, Salazar L, Rosales O, Nuñez L, Roca D and
Alcantara A: Mortality and associated risk factors in patients
hospitalized due to COVID-19 in a Peruvian reference hospital. PLoS
One. 17(e0264789)2022.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Mejía F, Medina C, Cornejo E, Morello E,
Vásquez S, Alave J, Schwalb A and Málaga G: Oxygen saturation as a
predictor of mortality in hospitalized adult patients with COVID-19
in a public hospital in Lima, Peru. PLoS One.
15(e0244171)2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Hueda-Zavaleta M, Copaja-Corzo C,
Bardales-Silva F, Flores-Palacios R, Barreto-Rocchetti L and
Benites-Zapata VA: Factors associated with mortality due to
COVID-19 in patients from a public hospital in Tacna, Peru. Rev
Peru Med Exp Salud Publica. 38:214–223. 2021.PubMed/NCBI View Article : Google Scholar : (In Spanish,
English).
|
|
22
|
COVID-19 Excess Mortality Collaborators.
Estimating excess mortality due to the COVID-19 pandemic: A
systematic analysis of COVID-19-related mortality, 2020-21. Lancet.
399:1513–1536. 2022.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Williamson EJ, Walker AJ, Bhaskaran K,
Bacon S, Bates C, Morton CE, Curtis HJ, Mehrkar A, Evans D,
Inglesby P, et al: Factors associated with COVID-19-related death
using OpenSAFELY. Nature. 584:430–436. 2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Anyaypoma-Ocón W, Vásquez SÑ,
Bustamante-Chávez HC, Sedano-De La Cruz E, Zavaleta-Gavidia V and
Angulo-Bazán Y: Factors associated with covid-19 lethality in a
hospital in the cajamarca region in peru. Rev Peru Med Exp Salud
Publica. 38:501–511. 2021.PubMed/NCBI View Article : Google Scholar : (In Spanish,
English).
|
|
25
|
Díaz-Vélez C, Urrunaga-Pastor D,
Romero-Cerdán A, Peña-Sánchez ER, Mogollon JL, Chafloque JD, Ascoy
GC and Benites-Zapata VA: Risk factors for mortality in
hospitalized patients with COVID-19 from three hospitals in Peru: A
retrospective cohort study. F1000Res. 10(224)2021.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Holman N, Knighton P, Kar P, O'Keefe J,
Curley M, Weaver A, Barron E, Bakhai C, Khunti K, Wareham NJ, et
al: Risk factors for COVID-19-related mortality in people with type
1 and type 2 diabetes in England: A population-based cohort study.
Lancet Diabetes Endocrinol. 8:823–833. 2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Galiero R, Loffredo G, Simeon V, Caturano
A, Vetrano E, Medicamento G, Alfano M, Beccia D, Brin C, Colantuoni
S, et al: Impact of liver fibrosis on COVID-19 in-hospital
mortality in Southern Italy. PLoS One. 19(e0296495)2024.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Galiero R, Pafundi PC, Simeon V, Rinaldi
L, Perrella A, Vetrano E, Caturano A, Alfano M, Beccia D, Nevola R,
et al: Impact of chronic liver disease upon admission on COVID-19
in-hospital mortality: Findings from COVOCA study. PLoS One.
15(e0243700)2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Hu B, Guo H, Zhou P and Shi ZL:
Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol.
19:141–154. 2021.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Muñoz-Rodríguez JR, Gómez-Romero FJ,
Pérez-Ortiz JM, López-Juárez P, Santiago JL, Serrano-Oviedo L and
Redondo-Calvo FJ: COVID-19 SESCAM Network. Characteristics and risk
factors associated with mortality in a multicenter spanish cohort
of patients with COVID-19 pneumonia. Arch Bronconeumol. 57:34–41.
2021.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Soares RCM, Mattos LR and Raposo LM: Risk
factors for hospitalization and mortality due to COVID-19 in
Espírito Santo State, Brazil. Am J Trop Med Hyg. 103:1184–1190.
2020.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Berenguer J, Ryan P, Rodríguez-Baño J,
Jarrín I, Carratalà J, Pachón J, Yllescas M and Arriba JR:
COVID-19@Spain Study Group; Fundación SEIMC-GESIDA et al.
Characteristics and predictors of death among 4035 consecutively
hospitalized patients with COVID-19 in Spain. Clin Microbiol
Infect. 26:1525–1536. 2020.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Aksel G, İslam MM, Algın AE, Emre S, Yaşar
GB, Ademoğlu E and Dölek ÜC: Early predictors of mortality for
moderate to severely ill patients with Covid-19. Am J Emerg Med.
45:290–296. 2021.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Rechtman E, Curtin P, Navarro E, Nirenberg
S and Horton MK: Vital signs assessed in initial clinical
encounters predict COVID-19 mortality in an NYC hospital system.
Sci Rep. 10(21545)2020.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Mol MBA, Strous MTA, van Osch FHM,
Vogelaar FJ, Barten DG, Farchi M, Foudraine NA and Gidron Y:
Heart-rate-variability (HRV), predicts outcomes in COVID-19. PLoS
One. 16(e0258841)2021.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Rastad H, Ejtahed HS, Mahdavi-Ghorabi A,
Arzaghi M, Safari A, Shahrestanaki E, Rezaei M, Niksima MM, Zakani
A, Manshadi SH, et al: Factors associated with the poor outcomes in
diabetic patients with COVID-19. J Diabetes Metab Disord.
19:1293–1302. 2020.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Shi L and Wang Y, Liang X, Xiao W, Duan G,
Yang H and Wang Y: Is neutrophilia associated with mortality in
COVID-19 patients? A meta-analysis and meta-regression. Int J Lab
Hematol. 42:e244–e247. 2020.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Zhang L, Hou J, Ma FZ, Li J, Xue S and Xu
ZG: The common risk factors for progression and mortality in
COVID-19 patients: A meta-analysis. Arch Virol. 166:2071–2087.
2021.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Li J, Zhang K, Zhang Y, Gu Z and Huang C:
Neutrophils in COVID-19: Recent insights and advances. Virol J.
20(169)2023.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Ali ET, Jabbar AS, Al Ali HS, Hamadi SS,
Jabir MS and Albukhaty S: Extensive study on hematological,
immunological, inflammatory markers, and biochemical profile to
identify the risk factors in COVID-19 patients. Int J Inflam.
2022(5735546)2022.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Chen R, Sang L, Jiang M, Yang Z, Jia N, Fu
W, Xie J, Guan W, Liang W, Ni Z, et al: Longitudinal hematologic
and immunologic variations associated with the progression of
COVID-19 patients in China. J Allergy Clin Immunol. 146:89–100.
2020.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Novida H, Soelistyo SA, Cahyani C, Siagian
N, Hadi U and Pranoto A: Factors associated with disease severity
of COVID-19 in patients with type 2 diabetes mellitus. Biomed Rep.
18(8)2023.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Galiero R, Simeon V, Loffredo G, Caturano
A, Rinaldi L, Vetrano E, Medicamento G, Alfano M, Beccia D, Brin C,
et al: Association between renal function at admission and COVID-19
in-hospital mortality in Southern Italy: Findings from the
prospective multicenter Italian COVOCA study. J Clin Med.
11(6121)2022.PubMed/NCBI View Article : Google Scholar
|
|
44
|
ARDS Definition Task Force. Ranieri VM,
Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E,
Camporota L and Slutsky AS: Acute respiratory distress syndrome:
The Berlin definition. JAMA. 307:2526–2533. 2012.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Grasselli G, Greco M, Zanella A, Albano G,
Antonelli M, Bellani G, Bonanomi E, Cabrini L, Carlesso E, Castelli
G, et al: Risk factors associated with mortality among patients
with COVID-19 in intensive care units in Lombardy, Italy. JAMA
Intern Med. 180:1345–1355. 2020.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Gu Y, Wang D, Chen C, Lu W, Liu H, Lv T,
Song Y and Zhang F: PaO2/FiO2 and IL-6 are risk factors of
mortality for intensive care COVID-19 patients. Sci Rep.
11(7334)2021.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Gao J, Zhong L, Wu M, Ji J and Liu Z, Wang
C, Xie Q and Liu Z: Risk factors for mortality in critically ill
patients with COVID-19: A multicenter retrospective case-control
study. BMC Infect Dis. 21(602)2021.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Tobin MJ, Laghi F and Jubran A: Why
COVID-19 silent hypoxemia is baffling to physicians. Am J Respir
Crit Care Med. 202:356–360. 2020.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Santus P, Radovanovic D, Saderi L, Marino
P, Cogliati C, De Filippis G, Rizzi M, Franceschi E, Pini S,
Giuliani F, et al: Severity of respiratory failure at admission and
in-hospital mortality in patients with COVID-19: A prospective
observational multicentre study. BMJ Open.
10(e043651)2020.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Rinaldi L, Lugarà M, Simeon V, Perrotta F,
Romano C, Iadevaia C, Sagnelli C, Monaco L, Altruda C, Fascione MC,
et al: Application and internal validation of lung ultrasound score
in COVID-19 setting: The ECOVITA observational study. Pulmonology.
17(29)2024.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Soto-Becerra P, Culquichicón C,
Hurtado-Roca Y and Araujo-Castillo RV: Real-world effectiveness of
hydroxychloroquine, azithromycin, and ivermectin among hospitalized
COVID-19 patients: Results of a target trial emulation using
observational data from a nationwide healthcare system in Peru.
medRxiv and bioRxiv. 51:191–192. 2020.
|
|
52
|
Llanos-Cuentas A, Schwalb A, Quintana JL,
Delfin B, Alvarez F, Ugarte-Gil C, Gronerth RI, Lucchetti A, Grogl
M and Gotuzzo E: Hydroxychloroquine to prevent SARS-CoV-2 infection
among healthcare workers: Early termination of a phase 3,
randomised, open-label, controlled clinical trial. BMC Res Notes.
16(22)2023.PubMed/NCBI View Article : Google Scholar
|
|
53
|
RECOVERY Collaborative Group. Horby P, Lim
WS, Emberson JR, Mafham M, Bell JL, Linsell L, Brightling C,
Ustianowski A, Elmahi E, et al: Dexamethasone in hospitalized
patients with Covid-19. N Engl J Med. 384:693–704. 2021.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Rayman G, Lumb AN, Kennon B, Cottrell C,
Nagi D, Page E, Voigt D, Courtney HC, Atkins H, Higgins K, et al:
Dexamethasone therapy in COVID-19 patients: Implications and
guidance for the management of blood glucose in people with and
without diabetes. Diabet Med. 38(e14378)2021.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Marfella R, D'Onofrio N, Sardu C,
Scisciola L, Maggi P, Coppola N, Romano C, Messina V, Turriziani F,
Siniscalchi M, et al: Does poor glycaemic control affect the
immunogenicity of the COVID-19 vaccination in patients with type 2
diabetes: The CAVEAT study. Diabetes Obes Metab. 24:160–165.
2022.PubMed/NCBI View Article : Google Scholar
|
